If you've started waking at 3 a.m. wide awake, lying there with your mind running, you're in very good company. Sleep trouble is one of the most common and most frustrating parts of perimenopause, and it's one of the earliest signs for many women.
Hormones are often part of the story, and so let’s chat about it. And in my practice, I never stop at “it’s your hormones,” because sleep at midlife is not always just one thing. This post walks through what's happening physiologically, what the research does and doesn't show, and how we sort out what's driving your sleep.
Why progesterone is often the first hormone to change
Progesterone is made mainly after ovulation. When a follicle releases an egg, what's left behind becomes the corpus luteum, a temporary structure that produces progesterone for roughly the next two weeks.
That design exists to protect a possible pregnancy. If an embryo implants, it signals the corpus luteum to keep going, and the corpus luteum keeps producing progesterone until the placenta is established and takes over [1].
Now consider what happens when ovulation becomes less reliable. No ovulation means no corpus luteum, and so very little progesterone. In a study that followed 108 women through the menopausal transition, more than 60% of cycles in late perimenopause were anovulatory [2]. Even in cycles where ovulation still happens, progesterone in the second half of the cycle drops as the transition progresses [3].
This is why perimenopause isn't simply "all hormones going down." In the same research, estradiol in ovulatory cycles actually rose as women moved through the transition [3], and a smaller earlier study found higher estrogen metabolites in perimenopausal women than in younger women [4]. The picture is more like a hormone pattern that becomes erratic, with progesterone often the first to fall short. That unpredictability is often the hardest part. When your sleep, mood, or energy shifts from one week to the next without an obvious reason, it’s easy to wonder what you’re doing wrong. Often, the answer is nothing. Your hormones are simply less predictable than they used to be.
What progesterone does in the brain
Progesterone doesn't just act on the uterus. Your brain converts some of it into a metabolite called allopregnanolone. This molecule enhances the action of GABA, your brain's main calming (inhibitory) neurotransmitter, by acting on GABA-A receptors [5]. This is the same receptor family that benzodiazepines and many sleep medications act on. In animal studies, allopregnanolone shortened the time to fall asleep and altered sleep in a benzodiazepine-like way [6].
That mechanism is well described in the lab. What it means for a woman in perimenopause is less certain. A systematic review of nine randomized trials (388 participants, nearly all postmenopausal women) found that micronized progesterone improved some sleep measures. Time to fall asleep improved on sleep-lab testing, but total sleep time and sleep efficiency did not, and the authors noted that concurrent estradiol and improvement in hot flashes limit what we can conclude [7]. In a small crossover study of 10 healthy postmenopausal women, progesterone reduced time spent awake during the night [8].
The mechanism makes sense, and the early research is encouraging. We’re still learning, and perimenopause in particular needs a lot more study, but it’s a promising place to start. My hunch is that perimenopause is simply harder to study. When your hormones look different from one cycle to the next, a treatment’s effect can get lost in all that natural variation.
Where does cortisol fit?
Cortisol normally rises through the early morning hours and peaks shortly after waking, which is part of what gets you going. It's natural to wonder whether low progesterone and cortisol are connected.
I looked, and I can't point to research showing that progesterone directly changes cortisol in perimenopause. A meta-analysis of 121 studies found cortisol was slightly higher in the first half of the cycle than the second, but the effect was small, and the authors called for more rigorous work [9].
What the research does support is the reverse direction: disrupted sleep disrupts cortisol. In an experimental study of young women, fragmenting their sleep raised bedtime cortisol by 27% and blunted the morning cortisol rise by 57%. Lowering estradiol independently lowered bedtime cortisol [10]. In peri- and postmenopausal women, worse sleep architecture was linked with higher cortisol [11], and women with more hot flashes had a blunted morning cortisol rise [12].
So the likely picture is a loop: hormone shifts and hot flashes fragment sleep, fragmented sleep changes cortisol timing, and that can make mornings and nights feel worse. It's a reasonable hypothesis, but the loop is not yet fully mapped.
Estrogen, and does timing matter?
Estrogen therapy can improve sleep, especially when hot flashes are the problem. A meta-analysis of 15 trials found hormone therapy improved self-reported sleep, though not sleep measured in a sleep lab. Transdermal routes (patch or gel) looked more beneficial than oral routes, though those comparisons were across different trials [13]. In a small study of 11 postmenopausal women, a patch increased REM sleep and reduced time awake in the early part of the night [14]. In a larger trial of women with hot flashes, low-dose oral estradiol modestly improved sleep quality scores, though results were mixed across the two scales used [15].
What I could not find is any trial testing whether taking estrogen in the evening versus the morning changes sleep. If you've heard that bedtime estrogen is better, that's a reasonable clinical thought, especially if you’re having night sweats, but it isn't established. Timing is a conversation to have with your prescriber based on your symptoms and the form you're using.
Waking up to pee
Many women notice waking to use the bathroom as perimenopause progresses, and it's honestly unclear which comes first, waking and then feeling the urge, or the bladder waking you. Most likely, it’s a bit of both. If this is happening to you, you know how frustrating it is. You get up for what should be a quick trip, and by the time you’re back in bed, your mind is switched on and sleep feels far away.
As estrogen declines, the tissues of the vagina, urethra and bladder can become thinner, drier, and less elastic. This is called genitourinary syndrome of menopause (GSM), the current medical term for what used to be called vaginal atrophy [16]. It can show up as dryness, discomfort with intercourse, urinary urgency, frequent urination, and more urinary tract infections. Reviews suggest estrogen decline may contribute to nighttime urination through several routes: a smaller functional bladder capacity, more urine made overnight, and disrupted sleep itself [17]. Hormone therapy may help nocturia, possibly in part because it improves sleep [18].
Because there are many causes of nighttime urination, this is where testing comes in. A urinalysis is part of the standard evaluation, and we also look at the other causes: blood sugar (diabetes is a key one), fluid timing, medications, and sleep apnea [19]. If there's a low-grade infection, that's one for your family doctor to treat with antibiotics.
After that, the goal is prevention. Vaginal estrogen has the strongest evidence here. Compared with placebo, it improves dryness, painful intercourse, urgency and frequency, and lowers UTI rates [20]. A meta-analysis found vaginal estrogen cut recurrent UTIs by more than half, while oral estrogen showed no benefit for this purpose [21].
Probiotics are more uncertain. A Cochrane review found no significant reduction in recurrent UTIs, with a high risk of bias in the studies [22], and a 2026 review of vaginal and oral Lactobacillus in postmenopausal women found mixed results, with some studies showing improvements [23]. This is where clinical judgment helps fill in the gaps. One approach I learned from my mentor is to use vaginal probiotics to support the vaginal flora, followed by oral probiotics to help maintain it. This can be an option to discuss if you’re not ready to start vaginal estrogen, and if symptoms don’t improve, vaginal estrogen is still very much on the table. Everyone responds differently, so this is something we’d monitor together.
Why we test, and why one hormone is rarely the whole story
Yes, I recommend testing here too. Hormone levels swing widely in perimenopause, so a single number is a snapshot of one moment, and timing in your cycle matters when interpreting it. Testing is most useful alongside your symptom pattern and often your cycle tracking.
Beyond hormones, we look at the things that commonly overlap with sleep trouble and fatigue: thyroid, iron stores, blood sugar, vitamin B12, and other contributors (the same logic as in my post, Perimenopause, Anxiety, or Thyroid? Why Testing Matters). Reviews of perimenopausal sleep are consistent that it's multifactorial: hormone shifts, hot flashes, mood, circadian changes, and aging all play a part [24].
The research on patterns is worth knowing:
In a large community study, difficulty falling asleep and staying asleep increased as women moved through the transition [25].
Hot flashes are a real sleep disruptor. In an experimental model, most nighttime hot flashes occurred in or right before an awakening, and the perception of the hot flash was linked to disrupted sleep [26].
But hot flashes don't explain everything. Even after accounting for hot flashes and depressive symptoms, lower estradiol and higher FSH were associated with sleep disturbance, particularly awakenings [27]. A 2025 review concluded that both hot flashes and hormones predict sleep problems, but neither fully explains them [28].
I haven't found a reliable way to tell which hormone is behind your sleep from symptom pattern alone. Waking drenched in sweat points toward the hot flash pathway, and that's a useful clue, but it's a clue, not a diagnosis.
Putting it together
Sleep in perimenopause is rarely one thing. It can be progesterone, estrogen, hot flashes, a bladder that wakes you, a thyroid or iron issue, stress physiology, or several together. Iron in particular deserves its own conversation, since it can affect both how you sleep and how rested you feel, so I’ll be diving into that in an upcoming post. My approach is to test rather than guess, treat what we find, and build from there: sleep-focused therapy (CBT for insomnia has strong evidence for menopausal insomnia [27]), targeted support, and hormone therapy where it fits.
In my next post, I’ll dig into the research on progesterone therapy, transdermal versus oral forms, and the herbs and supplements I find myself reaching for most often.
If this sounds like you, I offer virtual care in Ontario and Manitoba. You can book an appointment through Jane, or send me a question through the contact form.
General information only, not medical advice.
References
1. Järvelä IY, Ruokonen A, Tekay A. Effect of rising hCG levels on the human corpus luteum during early pregnancy. Hum Reprod. 2008;23(12):2775-81. doi:10.1093/humrep/den299
2. O'Connor KA, et al. Progesterone and ovulation across stages of the transition to menopause. Menopause. 2009;16(6):1178-87. doi:10.1097/gme.0b013e3181aa192d
3. Hale GE, et al. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the STRAW staging system. J Clin Endocrinol Metab. 2007;92(8):3060-7. doi:10.1210/jc.2007-0066
4. Santoro N, et al. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab. 1996;81(4):1495-501. doi:10.1210/jcem.81.4.8636357
5. Carver CM, Reddy DS. Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors. Psychopharmacology. 2013;230(2):151-88. doi:10.1007/s00213-013-3276-5
6. Lancel M, et al. Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther. 1997;282(3):1213-8.
7. Nolan BJ, Liang B, Cheung AS. Efficacy of micronized progesterone for sleep: a systematic review and meta-analysis of randomized controlled trial data. J Clin Endocrinol Metab. 2021;106(4):942-51. doi:10.1210/clinem/dgaa873
8. Schüssler P, et al. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology. 2008;33. doi:10.1016/j.psyneuen.2008.05.013
9. Klusmann H, et al. HPA axis activity across the menstrual cycle: a systematic review and meta-analysis of longitudinal studies. Front Neuroendocrinol. 2022;66:100998. doi:10.1016/j.yfrne.2022.100998
10. Cohn AY, et al. Effects of sleep fragmentation and estradiol decline on cortisol in a human experimental model of menopause. J Clin Endocrinol Metab. 2023;108(11):e1347-57. doi:10.1210/clinem/dgad285
11. Sahola N, et al. Worse sleep architecture but not self-reported insomnia and sleepiness is associated with higher cortisol levels in menopausal women. Maturitas. 2024;187:108053. doi:10.1016/j.maturitas.2024.108053
12. Sauer T, et al. Perimenopausal vasomotor symptoms and the cortisol awakening response. Menopause. 2020;27(11):1322-7. doi:10.1097/GME.0000000000001588
13. Pan Z, et al. Different regimens of menopausal hormone therapy for improving sleep quality: a systematic review and meta-analysis. Menopause. 2022;29(5):627-35. doi:10.1097/GME.0000000000001945
14. Antonijevic IA, Stalla GK, Steiger A. Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol. 2000;182(2):277-82. doi:10.1016/s0002-9378(00)70211-0
15. Ensrud KE, et al. Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes. Sleep. 2015;38(1):97-108. doi:10.5665/sleep.4332
16. Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from ISSWSH and NAMS. Menopause. 2014;21(10):1063-8. doi:10.1097/GME.0000000000000329
17. Pauwaert K, Everaert K. Nocturia through the menopausal transition and beyond: a narrative review. Int Urogynecol J. 2021;32. doi:10.1007/s00192-020-04640-7
18. Pauwaert K, Calders P, Weiss JP. Nocturia in menopausal women: the link between two common problems of the middle age. Int Urogynecol J. 2024;35. doi:10.1007/s00192-024-05743-1
19. Getaneh FW, Sussman RD, Iglesia CB. Nocturia: evaluation and management. Am Fam Physician. 2025;111(6):515-23.
20. Rahn DD, et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol. 2014;124(6):1147-56. doi:10.1097/AOG.0000000000000526
21. Chen YY, et al. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials. Int Urogynecol J. 2021;32. doi:10.1007/s00192-020-04397-z
22. Schwenger EM, et al. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015;(12):CD008772. doi:10.1002/14651858.CD008772.pub2
23. Tsuboi I, et al. Effect of Lactobacillus-based probiotics on genitourinary syndrome of menopause in post-menopausal women: a systematic review. Maturitas. 2026;208:108921. doi:10.1016/j.maturitas.2026.108921
24. Troìa L, et al. Sleep disturbance and perimenopause: a narrative review. J Clin Med. 2025;14(5):1479. doi:10.3390/jcm14051479
25. Kravitz HM, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31(7):979-90.
26. Bianchi MT, et al. Nocturnal hot flashes: relationship to objective awakenings and sleep stage transitions. J Clin Sleep Med. 2016;12(7):1003-9. doi:10.5664/jcsm.5936
27. Baker FC. Optimizing sleep across the menopausal transition. Climacteric. 2023;26(3):198-205. doi:10.1080/13697137.2023.2173569
28. Carmona NE, Solomon NL, Adams KE. Sleep disturbance and menopause. Curr Opin Obstet Gynecol. 2025;37(2):75-82. doi:10.1097/GCO.0000000000001012